Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ME - 23andMe Holding Co - Ordinary Shares - Class A


IEX Last Trade
0.3137
0.005   1.498%

Share volume: 928,783
Last Updated: Fri 30 Aug 2024 09:59:48 PM CEST

PREVIOUS CLOSE
CHG
CHG%

$0.31
0.00
1.52%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
-2.63%
1 Month
-22.61%
3 Months
-43.59%
6 Months
-48.76%
1 Year
-72.62%
2 Year
-90.10%
Key data
Stock price
$0.31
P/E Ratio 
-0.17
DAY RANGE
N/A - N/A
EPS 
-$1.30
52 WEEK RANGE
$0.30 - $1.16
52 WEEK CHANGE
-$0.72
MARKET CAP 
106.909 M
YIELD 
N/A
SHARES OUTSTANDING 
339.503 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.65
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,188,411
AVERAGE 30 VOLUME 
$2,878,031
Company detail
CEO:
Region: US
Website: 23andme.com
Employees: 857
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

23andme is the leading personal genetics company dedicated to helping individuals understand their own genetic information through dna analysis technologies and web-based interactive tools. the company's personal genome service® enables individuals to gain deeper insights into their ancestry and genetic make-up. the vision for 23andme is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andme was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science.

Recent news